Mirror-image molecules can modify signaling in neurons

(Press-News.org) With the aid of some sea slugs, University of Nebraska–Lincoln chemists have discovered that one of the smallest conceivable tweaks to a biomolecule can elicit one of the grandest conceivable consequences: directing the activation of neurons.

Their discovery came from investigating peptides, the short chains of amino acids that can transmit signals among cells, including neurons, while populating the central nervous systems and bloodstreams of most animals. Like many other molecules, an amino acid in a peptide can adopt one of two forms that feature the same atoms, with the same connectivity, but in mirror-image orientations: L and D.

Chemists often think of those two orientations as the left and right hands of a molecule. The L orientation is by far the more common in peptides, to the point of being considered the default. But when enzymes do flip an L to a D, the seemingly minor about-face can turn, say, a potentially therapeutic molecule into a toxic one, or vice versa.

Now, Husker chemists James Checco, Baba Yussif and Cole Blasing have revealed a whole new role for that molecular mirroring. For the first time, the team has shown that the orientation of a single amino acid — in this case, one of dozens found in the neuropeptide of a sea slug — can dictate the likelihood that the peptide activates one neuron receptor versus another. Because different types of receptors are responsible for different neuronal activities, the finding points to another means by which a brain or nervous system can regulate the labyrinthine, life-sustaining communication among its cells.

“We’ve discovered a new way that biology works,” said Checco, assistant professor of chemistry at Nebraska. “It’s nature’s way of helping to make sure that the peptide goes to one signaling pathway versus the other. And understanding more about that biology will help us to be able to take advantage of it for future applications.”

Checco’s interest in neuropeptide signaling dates back to his time as a postdoctoral researcher, when he came across the first study to show evidence of a peptide with a D-amino acid activating a neuron receptor in sea slugs. That particular receptor responded to the peptide only when it contained the D-amino acid, making its flip from L to D akin to an on/off switch.

Eventually, Checco himself would identify a second such receptor. Unlike the one that had initially sparked his interest, Checco’s receptor responded both to a peptide featuring all L-amino acids and the same peptide with a single D. But the receptor was also more responsive to the all-L peptide, activating when introduced to smaller concentrations of it than its D-containing counterpart. Instead of an on/off switch, Checco seemed to have found something closer to a dimmer.

“We were left wondering: Is this the whole story?” Checco said. “What’s really going on? Why make this D molecule if it’s even worse at activating the receptor?”

The team’s newest findings, detailed in the journal Proceedings of the National Academy of Sciences, hint at an answer inspired by a hypothesis. Maybe, the team thought, there were other receptors in the sea slug sensitive to that D-containing peptide. If so, maybe some of those receptors would respond differently to it.

Yussif, a doctoral candidate in chemistry, went to work searching for sea slug receptors whose genetic blueprints resembled those of the one Checco had uncovered. He ultimately narrowed down a list of candidates, which the team then cloned and managed to express in cells before introducing them to the same D-containing peptide as before. One of the receptors responded. But this receptor — in an almost mirror-image performance of Checco’s original — responded much more favorably to the D-containing peptide than its all-L peer.

“You can see a pretty dramatic shift,” Checco said, “where now the D is, in fact, much more potent than the L at activating this new receptor.”

In effect, the team realized, the orientation of that lone amino acid was directing its peptide to activate either one receptor or the other. In its all-L state, the neurotransmitter preferred Checco’s original. When that certain L turned D, on the other hand, it went for Yussif’s new candidate instead.

Central nervous systems rely on different types of neurotransmitters to send various signals to various receptors, with dopamine and serotonin among those best-known in humans. Given the radical complexity and delicacy of the signaling in many animals, though, Checco said it makes some sense that they might evolve equally sophisticated ways of fine-tuning the signals sent by even a single neuropeptide.

“These sorts of communication processes need to be very, very highly regulated,” Checco said. “You need to make the right molecule. It needs to be released at the right time. It needs to be released at the right site. It needs to degrade, actually, in a certain amount of time, so that you don’t have too much signaling.

“So you have all this regulation,” he said, “and now this is a whole new level of it.”

Unfortunately for Checco and others like him, naturally occurring peptides that contain D-amino acids are difficult to identify using the instrumentation readily available to most labs. He suspects it’s one reason that, at least to date, no D-containing peptides have been found in people. He also suspects that will change — and that, when it does, it could help researchers better grasp both the function and disease-related dysfunction of signaling in the brain.

“I think it is likely that we will find peptides with this kind of modification in humans,” Checco said. “And that’s going to potentially open up new therapeutic avenues in terms of that specific target. Understanding more about how these things are functioning could be exciting there.”

In the meantime, Checco, Yussif and Blasing, a senior double-majoring in biochemistry and chemistry, are busy trying to answer other questions. For starters, they wonder whether an all-L versus D-containing peptide — even those equally likely to activate a receptor — might activate that receptor in different ways, with different cellular consequences. And the search for receptors won’t stop, either.

“This is one receptor system, but there are others,” Checco said. “So I think we want to start to extend and discover new receptors for more of these peptides, to really get a bigger picture about how this modification influences signaling and function.

“Where I really want to go long-term with this project,” he said, “is to get a better idea, across all of biology, of what this modification does.”

END